Zomig Rapimelt 2.5mg (Zolmitriptan)
Prescription-only Zomig Rapimelt containing zolmitriptan 2.5 mg for the acute treatment of migraine attacks, where clinically appropriate.
The orodispersible tablet is designed to dissolve in the mouth. An online clinical assessment and approval are required before supply.
Medicine information
Active ingredient: Zolmitriptan 2.5 mg per tablet.
Product: Zomig Rapimelt.
Formulation: Orodispersible tablet (Rapimelt).
Purpose: Acute treatment of migraine attacks where clinically appropriate. This medicine does not prevent future attacks.
Pack information: Confirm pack quantity before ordering.
Other ingredients and formulation notes: The branded Rapimelt formulation dissolves on the tongue. Contains aspartame, which is a source of phenylalanine; check the patient leaflet if you have phenylketonuria.
Safety and supply: Requires clinical assessment and approval before supply. Tell the prescriber about cardiovascular conditions, other migraine medicines, antidepressants and all other medication. Use only as directed by your prescriber. Excessive use of acute headache medication can worsen headaches.
Patient leaflet: Check the supplied manufacturer's patient information leaflet for full ingredients, contraindications, dosage and side effects. Product information reference.